Cardiac Rehabilitation Implementation Guide to Enhance Patient Referrals & Engagement

Despite the many benefits of Cardiac Rehabilitation, enrollment remains quite low – nationally, only 10% to 34% of eligible patients enroll. This resource provides guidance and tools to support awareness of the value of Cardiac Rehabilitation with patients, reduce barriers to participation, and implement evidence-based interventions, such as automatic referral with care coordination, to increase enrollment and patient engagement.

Cardiac Rehabilitation Programs – New England, New York, New Jersey, Ohio & Mid Atlantic Regions

Hospitals may treat patients who are eligible for outpatient cardiac rehabilitation (CR) that do not live or work nearby. Developing and maintaining a list of active CR programs with the facility’s address, contact information, and other relevant details can help CR care coordinators find a program that may be more convenient for the patient.

Regional listing for the following IPRO QIN-QIO areas are available:

Mid Atlantic (DC, DE & MD)

New England (CT, MA, ME, NH, RI & VT)

New York, New Jersey & Ohio

CDC Clinical Practice Guideline for Prescribing Opioids for Pain – Updated November 2022

This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1–49) and includes recommendations for managing acute (duration of <1 month), subacute (duration of 1–3 months), and chronic (duration of >3 months) pain.

The recommendations do not apply to pain related to sickle cell disease or cancer or to patients receiving palliative or end-of-life care.

The guideline addresses the following four areas:

1) determining whether or not to initiate opioids for pain,

2) selecting opioids and determining opioid dosages,

3) deciding duration of initial opioid prescription and conducting follow-up, and

4) assessing risk and addressing potential harms of opioid use.

CDC developed the guideline using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. Recommendations are based on systematic reviews of the scientific evidence and reflect considerations of benefits and harms, patient and clinician values and preferences, and resource allocation.

CDC obtained input from the Board of Scientific Counselors of the National Center for Injury Prevention and Control (a federally chartered advisory committee), the public, and peer reviewers.

CDC recommends that persons with pain receive appropriate pain treatment, with careful consideration of the benefits and risks of all treatment options in the context of the patient’s circumstances.

Chronic Kidney Disease (CKD) Screening and Management Mobile Apps

Webpage to access the web-based, Apple App Store, and Google Play versions of the Clinician CKD Screening app and the patient-centered Kidney Choices app. IPRO’s Clinician CKD Screening and Patient-Centered Kidney Choices apps were designed to:
-Help identify CKD early in at-risk patients and to help manage CKD
-To help delay progression
-To provide kidney replacement information for patients whose CKD has progressed to kidney failure.

Chronic Kidney Disease Awareness and Prevention Program

To recognize National Kidney Month, the IPRO QIN-QIO launched an educational video series to increase patient health literacy and help patients make informed choices about preventing and managing chronic kidney disease (CKD).

These videos cover important CKD-related topics, including prevention, screening and diagnosis, and management. The series was designed with input from diverse IPRO QIN-QIO Patient and Family Advisory Council members. You are encouraged to share these videos with your patients, residents, and their families. We’ll add more videos soon, so bookmark this page and check back frequently.

Chronic Kidney Disease Disparities: Educational Guide for Primary Care

This educational guide is intended to foster the development of primary care practice teams to enhance care for vulnerable patients who are at risk of CKD or who have CKD and are at risk of progression of disease or complications. This guide addresses three aspects of care: identification of CKD; treatment and monitoring progression; and delivering patient-centered care. It is meant to inform readers about disparities in the care of patients with CKD, present potential actions that may improve care and suggest other available resources that may be used by primary care practice teams in caring for vulnerable patients.

CMS Nursing Home Adverse Drug Event Trigger Tool

This tool was developed by CMS for use by nursing home surveyors and is a valuable resource for organizations that are focusing on preventing ADEs.

It was designed to help surveyors identify:

1. The extent to which facilities have identified resident-specific risk factors for adverse drug events

2. The extent to which facilities developed and implemented systems and processes to minimize risks associated with medications that are known to be high-risk and problem-prone

3. When a preventable adverse event has occurred, evaluate if the nursing home identified the issue and responded appropriately to mitigate harm to the individual and prevent recurrence.